Search results
Pfizer vs Moderna battle over COVID vaccine patents begins in UK
KFGO· 14 hours agoBy Sam Tobin LONDON (Reuters) - Pfizer and BioNTech asked a London court to revoke rival Moderna's...
...London Patent Battle over Covid-19 Vaccines In Legal Showdown - Moderna (NASDAQ:MRNA), Pfizer...
Benzinga· 10 hours agoModerna Inc. MRNA is set to clash with Pfizer Inc. PFE and BioNTech SE BNTX in a pivotal London...
Pfizer's (PFE) RSV Vaccine Study in Adults Under 60 Meets Goal
Zacks via Yahoo Finance· 2 weeks agoPfizer's (PFE) RSV vaccine, Abrysvo, generates an immune response in a phase III study evaluating it...
Moderna, Pfizer/BioNTech set for UK court clash over COVID jab patents
Medical Xpress· 21 hours agoA row between pharmaceutical firms Moderna and Pfizer/BioNTech comes to court in London on Tuesday...
Fact Check: mRNA Jabs Have Allegedly Caused a '14,000% Increase in Turbo Cancer.' Here's What We...
Snopes via Yahoo News· 4 days agoRating: Myriad publications have falsely warned readers about "turbo cancer," a purportedly...
Covid vaccines aren't linked to sudden death in young people, a new CDC report finds.
NBC News via Yahoo News· 2 weeks agoEver since the vaccines from Pfizer and Moderna were authorized in late 2020, anti-vaccination...
Rival Covid-19 jab developers face off in High Court patent trial
PA Media: Science via Yahoo News· 17 hours agovaccine was the third jab to be approved for use in the UK in January 2021 after the Pfizer/BioNTech...
Colleges backtrack as COVID vaccine mandate lawsuits proceed under SCOTUS mootness doctrine
Just the News· 2 weeks agoIt's not clear the taxpayer-funded institution, which tested the jabs for reduction of symptoms but...
Where Will Pfizer Stock Be in 10 Years?
Motley Fool via Yahoo Finance· 2 weeks agoPfizer return to glory in 10 years and prove to be a great buy again? Here's where the business may be a decade from now, and whether ...
The Zacks Analyst Blog Highlights UnitedHealth, Pfizer, BlackRock, The Hershey and Edison...
Zacks via Yahoo Finance· 2 weeks agovaccine and Paxlovid oral pill, on lower demand. Concerns remain about its long-term growth drivers...
